Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics

Trending on Bing

Trump’s big bill blocked
Attacker sentenced to 25 yrs
Hears citizenship case
Diagnosed with cancer
Under Secret Service probe
Beauty influencer shot dead
Statue stolen in Slovenia
Helped son in terror plot?
Arrested in Indonesia
Trespass charges dismissed
Charged with wife's murder
Joe Don Baker dies at 89
EU moves to settle case
Utah court orders new trial
KY auditor sues governor
Broadway composer dies
Baraka appears in court
Denver Airport outage
NJ Transit engineers strike
Air taxis at 2028 Olympics
Airstrikes on southern Gaza
AI data campus partnership
Charter to buy Cox
WTA chairman to retire
Meets Syrian counterpart
Says he will meet with Putin
CEO to step down
Nottoway Plantation fire
Under criminal investigation
CPSC warns of lead
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Novo Nordisk, Lars Fruergaard Jørgensen

CBS News on MSN · 4h
Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement."
STAT · 6h
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround
Lars Fruergaard Jørgensen is stepping down as Novo Nordisk CEO, with the company citing the stock's recent struggles.
Reuters on MSN · 2h
Novo Nordisk ousts CEO after falling behind in weight loss market
Pedersen and Stine Jacobsen COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.
2hon MSN
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...
5hon MSN
Novo Replaces CEO Jorgensen After Lilly Rivalry Hits Shares
Novo Nordisk A/S is replacing Chief Executive Officer Lars Fruergaard Jorgensen as the drugmaker wrestles with increased ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy